Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672368 · ClinicalTrials.gov registry record · Phase 2
The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures
A Phase 2 study of Disease or Disorder, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT05672368 is a Phase 2 study of Disease or Disorder that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 33 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05672368, a Phase 2 study of Disease or Disorder, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial test the effectiveness and safety of a single-port robotic device (the da Vinci single port \[SP\]1098) for use in abdominal and pelvic surgeries. The da Vinci SP1098 robotic device can be used to perform less invasive surgeries that allow entry into the body through a single, small incision. The use of this device during surgery may allow surgeons to perform complex procedures that result in less pain, fewer complications and side effects, and improved recovery.
Conditions Studied
Interventions
- DEVICE Robot-Assisted Surgery
Study Locations (1)
California
- City of Hope Comprehensive Cancer Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-04-26 |
| Est. Completion | 2026-01-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672368
The ClinicalTrials.gov registry entry for NCT05672368 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disease or Disorder appearing as the primary indexed condition, and to 1 intervention - of which Robot-Assisted Surgery is the first listed.
NCT05672368 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05672368 about?
NCT05672368 is a clinical study titled "The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures". This phase II trial test the effectiveness and safety of a single-port robotic device (the da Vinci single port \[SP\]1098) for use in abdominal and pelvic surgeries. The da Vinci SP1098 robotic device can be used to perform less invasive surgeries that allow entry into the body through a single, sm...
What is the current status of trial NCT05672368?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2024-04-26. Estimated completion is 2026-01-27.
What conditions does trial NCT05672368 study?
This clinical trial studies the following conditions: Disease or Disorder.
What interventions are being tested in trial NCT05672368?
The interventions under investigation include: Robot-Assisted Surgery (DEVICE).
Who is sponsoring clinical trial NCT05672368?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05672368 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.